Seán McCluskey

Seán McCluskey

Auto-generated profile, based on publicly available information

Seán McCluskey

Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2018 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
EOEwa Oleszycka
Ewa Oleszycka
SMSean McCluskey
Sean McCluskey
FSFiona A. Sharp
Fiona A. Sharp
NMNatalia Muñoz‐Wolf
Natalia Muñoz‐Wolf
EHEmily Hams
Emily Hams
ELEdward Lavelle
Edward Lavelle

9 November 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
CHCiaran Harte
Ciaran Harte
AGAoife L. Gorman
Aoife L. Gorman
SMS. McCluskey
S. McCluskey
MCMichael Carty
Michael Carty
ABAndrew Bowie
Andrew Bowie
ELEdward Lavelle
Edward Lavelle
There has been a move away from vaccines composed of whole or inactivated antigens toward subunit-based vaccines, which although safe, provide less immunological protection. As a result, the use of adjuvants to enhance and direct adaptive immune responses has become the focus of much targeted bovine vaccine research. However, the mechanisms by which adjuvants work to enhance immunological protection in many cases remains unclear, although this knowledge is critical to the rational design of effective next generation vaccines. This study aimed to investigate the mechanisms by which alum, a commonly used adjuvant in bovine vaccines, enhances IL-1β secretion in bovine peripheral blood mononuclear cells (PBMCs). Unlike the case with human PBMCs, alum promoted IL-1β secretion in a subset of bovine PBMCs without priming with a toll-like receptor agonist. This suggests that PBMCs from some cattle are primed to produce this potent inflammatory cytokine and western blotting confirmed the presence of preexisting pro-IL-1β in PBMCs from a subset of 8-month-old cattle. To address the mechanism underlying alum-induced IL-1β secretion, specific inhibitors identified that alum mediates lysosomal disruption which subsequently activates the assembly of an NLRP3, ASC, caspase-1, and potentially caspase-8 containing complex. These components form an inflammasome, which mediates alum-induced IL-1β secretion in bovine PBMCs. Given the demonstrated role of the NLRP3 inflammasome in regulating adaptive immunity in murine systems, these results will inform further targeted research into the potential of inflammasome activation for rational vaccine design in cattle.

7 March 2025 in Science Advances
Verified
Journal Article
Open access
ARAisling M. Rehill
Aisling M. Rehill
SMSeán McCluskey
Seán McCluskey
ALAnna E. Ledwith
Anna E. Ledwith
TRTristram A. J. Ryan
Tristram A. J. Ryan
BÜBetül Ünlü
Betül Ünlü
RPRoger J. S. Preston
Roger J. S. Preston
The pathogenic basis for increased thrombotic risk in individuals with inflammatory diseases is poorly understood. Myeloid cell “trained immunity” describes persistent innate immune cell memory arising from prior exposure to an inflammatory stimulus, leading to an enhanced immune response to subsequent unrelated stimuli. We identify enhanced myeloid cell prothrombotic activity as a maladaptive consequence of trained immunity. Lipopolysaccharide (LPS) stimulation of macrophages trained previously with β-glucan or heme exhibited significantly enhanced procoagulant activity compared to macrophages stimulated with LPS alone, which was mediated by enhanced acid sphingomyelinase–mediated tissue factor decryption. Furthermore, splenic monocytes isolated from β-glucan–trained mice revealed enhanced procoagulant activity up to 4 weeks after β-glucan administration compared to monocytes from control mice over the same time period. Moreover, hematopoietic progenitor cells and bone marrow interstitial fluid from β-glucan–trained mice had enhanced procoagulant activity compared to control mice. Trained immunity and associated metabolic perturbations may therefore represent an opportunity for targeted intervention in immunothrombotic disease development.

2 June 2020 in Blood Advances
Verified
Journal Article
Open access
PDF file
EGEimear M. Gleeson
Eimear M. Gleeson
ARAisling M. Rehill
Aisling M. Rehill
OFOrla Willis Fox
Orla Willis Fox
FAFionnuala Ni Ainle
Fionnuala Ni Ainle
CMCormac J. McDonnell
Cormac J. McDonnell
RPRoger J. S. Preston
Roger J. S. Preston
Key Points: High-density lipoprotein and apolipoprotein A-I enhance activated protein C cytoprotective activity. High-density lipoprotein and apolipoprotein A-I significantly increase the rate at which activated protein C degrades cytotoxic extracellular histones.

21 April 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ARAisling M. Rehill
Aisling M. Rehill
GLGemma Leon
Gemma Leon
SMSean McCluskey
Sean McCluskey
ISIngmar Schoen
Ingmar Schoen
YHYasmina Hernandez-Santana
Yasmina Hernandez-Santana
RPRoger J.S. Preston
Roger J.S. Preston
Background: Myeloid cell metabolic reprogramming is a hallmark of inflammatory disease, however, its role in inflammation-induced hypercoagulability is poorly understood. Objective/Methods: Using novel myeloid cell-based global haemostasis assays and murine models of immunometabolic disease, we evaluated the role of inflammation-associated metabolic reprogramming in regulating blood coagulation. Results: Glycolysis was essential for enhanced activated myeloid cell tissue factor expression and decryption, driving increased cell-dependent thrombin generation in response to inflammatory challenge. Similarly, inhibition of glycolysis enhanced activated macrophage fibrinolytic activity via reduced plasminogen activator inhibitor 1 (PAI-1)-activity. Macrophage polarisation or activation markedly increased endothelial protein C receptor (EPCR) expression on monocytes and macrophages, leading to increased myeloid cell-dependent protein C activation. Importantly, inflammation-dependent EPCR expression on tissue-resident macrophages was also observed in vivo . Adipose tissue macrophages from obese mice fed a high-fat diet exhibited significantly enhanced EPCR expression and APC generation compared to macrophages isolated from the adipose tissue of healthy mice. Similarly, the induction of colitis in mice prompted infiltration of EPCR + innate myeloid cells within inflamed colonic tissue that were absent from the intestinal tissue of healthy mice. Conclusion: Collectively, this study identifies immunometabolic regulation of myeloid cell hypercoagulability, opening new therapeutic possibilities for targeted mitigation of thrombo-inflammatory disease. ESSENTIALS: Inflammation-mediated glycolytic reprogramming enables myeloid cell-induced hypercoagulability and antifibrinolytic activity. 2-Deoxy-D-glucose (2-DG) inhibits the expression of transcription factors necessary for inflammation-induced procoagulant gene expression. Myeloid cell membrane regulation of tissue factor procoagulant activity is glycolysis-dependent. Activation of myeloid innate immunity dysregulates activated protein C anticoagulant pathway activity.

1 January 2017
Verified
Book Chapter
Closed access
NMN. Muñoz-Wolf
N. Muñoz-Wolf
SMS. McCluskey
S. McCluskey
ELE.C. Lavelle
E.C. Lavelle